| Debiopharm Research & Manufacturing SA - Pamorelin LA 11.25 mg, poudre et solvant pour suspension injectable à libération prolongée |
| 56349 | | 01 | | Pamorelin LA 11.25 mg | | poudre et solvant pour suspension injectable à libération prolongée | | L02AE04 | | Triptorelin | | 09.02.2005 | | |
|
| Composition |
| Praeparatio cryodesiccata: triptorelinum 11.25 mg ut triptorelini embonas, poly(lactidum-co-glycolidum), mannitolum, carmellosum natricum corresp. natrium 2.3 mg, polysorbatum 80, pro vitro.
Solvens: aqua ad iniectabile 2 ml. |
| Packungsbestandteile |
| Solvens | | aqua ad iniectabilia 2 ml | | | |
| Praeparatio cryodesiccata: | | | | | | | | Active Agent | Dose |
|---|
| Triptoreline | 11.25 mg |
| | | | Inactive agents |
|---|
| Carmellose Sodium | | Mannitol | | | | Polysorbatum 80 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Set(s) | 390.86 | 465.10 | A | | Yes |
|
